← Leaderboards
Chris H Wendt
Minneapolis Va Medical Center
$5,946,558
Attributed
$10,154,451
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $832K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,154,451 · 6
VA$0 · 1
By mechanism
R01$8,600,146 · 4
T32$1,156,065 · 1
R21$398,240 · 1
I01$0 · 1
Top collaborators
- Farrah Kheradmand6 shared
- Timothy J. Griffin4 shared
- Ken M. Kunisaki4 shared
- Ping Yang4 shared
- Filippo Coletti2 shared
- R. Adams Dudley2 shared
- David H Ingbar2 shared
Most similar at Minneapolis Va Medical Center
Same institution · by research overlap
- Farrah Kheradmand$15,730,322
- Alexa A Pragman$0
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungLung DiseasesBiological MarkersCohortChronicReportingPhenotypeInflammatoryBaseProteomeTechnologySmokeSiteMetabolomicsBiomarker DiscoveryProteomicsMultiple OmicsParticipantSphingolipidsSpirometryBioinformaticsPhysiologicalAffectSignal Transduction
Grant awards (27)
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures$0
I01 · FY2025 · VA · contact PI
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures$0
I01 · FY2024 · VA · contact PI
Training in Lung Science$324,046
T32 · FY2023 · HL · contact PI
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures$0
I01 · FY2023 · VA · contact PI
Training in Lung Science$832,019
T32 · FY2022 · HL · contact PI
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures$0
I01 · FY2022 · VA · contact PI
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$667,118
R01 · FY2021 · HL · contact PI
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures$0
I01 · FY2021 · VA · contact PI
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$667,118
R01 · FY2020 · HL · contact PI
CMA:Pulmonary and Systemic Effects of Deployment Related Particulate Matter Exposures$0
I01 · FY2020 · VA · contact PI
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$671,673
R01 · FY2019 · HL · contact PI
Spingolipids in HIV-associated Chronic Obstructive Pulmonary Disease$743,025
R01 · FY2018 · HL · contact PI
Identifying imaging-based biomarkers of COPD development through virtual inhalation experiments$228,000
R21 · FY2016 · HL
Identifying imaging-based biomarkers of COPD development through virtual inhalation experiments$170,240
R21 · FY2015 · HL
Common Pathogenetic Mechanisms of Lung Cancer and COPD$697,882
R01 · FY2014 · HL · contact PI
Common Pathogenetic Mechanisms of Lung Cancer and COPD$668,065
R01 · FY2013 · HL · contact PI
Common Pathogenetic Mechanisms of Lung Cancer and COPD$726,338
R01 · FY2012 · HL · contact PI
Common Pathogenetic Mechanisms of Lung Cancer and COPD$718,596
R01 · FY2011 · HL · contact PI
Protein Biomarkers in Lung Allograft Rejection$435,036
R01 · FY2010 · HL · contact PI
Protein Biomarkers in Lung Allograft Rejection$431,340
R01 · FY2009 · HL · contact PI
Protein Biomarkers in Lung Allograft Rejection$25,392
R01 · FY2009 · HL · contact PI
Protein Biomarkers in Lung Allograft Rejection$419,137
R01 · FY2008 · HL · contact PI
Protein Biomarkers in Lung Allograft Rejection$418,091
R01 · FY2007 · HL · contact PI
Na, K-ATPase Regulation by Glucocorticoids in Lung$316,811
R01 · FY2007 · HL · contact PI
Na, K-ATPase Regulation by Glucocorticoids in Lung$326,274
R01 · FY2006 · HL · contact PI
Na, K-ATPase Regulation by Glucocorticoids in Lung$334,125
R01 · FY2005 · HL
Na, K-ATPase Regulation by Glucocorticoids in Lung$334,125
R01 · FY2004 · HL